Cite
HARVARD Citation
Röth, A. et al. (2020). Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry. European journal of haematology. pp. 561-570. [Online].